市場調査レポート

商品コード

1786982

シクロスポリンの世界市場、規模、シェア、産業分析レポート：適応症別、剤形別、投与経路別、流通チャネル別、地域別 - 市場予測（2025年～2034年）

Cyclosporine Market Size, Share, & Industry Analysis Report By Indication (Transplant rejection prophylaxis, Rheumatoid arthritis), By Dosage Form, By Route of Administration, By Distribution Channel, and By Region - Market Forecast, 2025-2034

出版日: 2025年07月01日
発行: Polaris Market Research
ページ情報: 英文 125 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 640,815円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 791,595円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 942,375円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.78円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Researchの最新調査によると、世界のシクロスポリンの市場規模は、2034年までに70億6,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

シクロスポリンは、臓器移植の拒絶反応の予防や自己免疫疾患の管理に広く使用されている免疫抑制剤であり、治療の成功には正確な免疫調節が不可欠です。厳格な臨床プロトコルの下で開発され、制御された免疫反応と一貫した治療成果を保証します。ヘルスケアシステムが全身用および眼科用の高度な免疫抑制療法へのアクセスを拡大するにつれて、市場は成長を続けています。

市場成長の原動力となっているのは、政府のヘルスケア支出の増加と世界の臓器移植件数の増加です。ドラッグ製剤やデリバリーシステムの進歩が進み、患者のコンプライアンスや治療効率が向上しています。さらに、自己免疫疾患や慢性的な眼炎症が拡大していることが、複数の診療科でシクロスポリンの臨床採用を拡大する原動力となっています。

シクロスポリン市場レポートのハイライト

適応症別では、長期的な免疫抑制療法を必要とする腎臓、肝臓、心臓の移植手術件数が増加していることから、移植拒絶反応予防が2024年の市場を独占しています。

剤形別では、ドライアイと慢性眼表面炎の診断件数の増加により、点眼薬セグメントが最も急成長が見込まれます。

投与経路別では、経口が2024年に圧倒的な市場シェアを占め、これは全身性の自己免疫疾患での使用と、病院や小売チャネルで広く入手できることによります。

販売チャネル別では、院内薬局が2024年に圧倒的なシェアを占めました。これは、移植後の投薬レジメンを一元管理し、医師の監督下で免疫抑制剤を調剤する需要が高いためです。

北米は、旺盛なヘルスケア支出とジェネリック免疫抑制療法の堅調な採用により、2024年の世界シクロスポリン市場で最大のシェアを占めました。

アジア太平洋は、臓器移植へのアクセスの増加や自己免疫疾患の有病率の増加により、予測期間中に最も急成長する見込みです。

世界の主要市場企業には、AbbVie Inc.、AdvaCare Pharma、Apotex Inc.、Cipla Ltd.、Harrow, Inc.、Lupin Pharmaceuticals, Inc.、Novartis AG、参天製薬株式会社、Strides Pharma Science Ltd.、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries、Viatris Inc.などがあります。

市場スナップショット
シクロスポリン市場の力学
- 促進要因と機会
  - 政府のヘルスケア費支出の拡大
  - 世界的な臓器移植手術の増加
- 抑制要因と課題
  - 代替手段の可用性
  - 代替レクリエーションオプションとの競合
PESTEL分析
シクロスポリン市場の動向
バリューチェーン分析

第5章世界のシクロスポリン市場：適応症別

主な調査結果
イントロダクション
移植拒絶反応予防
関節リウマチ
乾癬
自己免疫性重症筋無力症
ドライアイ
その他の適応症

第6章世界のシクロスポリン市場：剤形別

主な調査結果
イントロダクション
カプセル
点眼薬
液体溶液
クリームと軟膏

第7章世界のシクロスポリン市場：投与経路別

主な調査結果
イントロダクション
経口
静脈内
局所

第8章世界のシクロスポリン市場：流通チャネル別

主な調査結果
イントロダクション
院内薬局
小売薬局
オンライン薬局

第9章世界のシクロスポリン市場：地域別

主な調査結果
イントロダクション
- シクロスポリン市場の分析：地域別、2020年～2034年
北米
- 北米：適応症別、2020～2034年
- 北米：剤形別、2020～2034年
- 北米：投与経路別、2020～2034年
- 北米：流通チャネル別、2020～2034年
- 米国
- カナダ
欧州
- 欧州：適応症別、2020～2034年
- 欧州：剤形別、2020～2034年
- 欧州：投与経路別、2020～2034年
- 欧州：流通チャネル別、2020～2034年
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋：適応症別、2020年～2034年
- アジア太平洋：剤形別、2020～2034年
- アジア太平洋：投与経路別、2020～2034年
- アジア太平洋：流通チャネル別、2020～2034年
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋
中東・アフリカ
- 中東・アフリカ：適応症別、2020年～2034年
- 中東・アフリカ：剤形別、2020～2034年
- 中東・アフリカ：投与経路別、2020～2034年
- 中東・アフリカ：流通チャネル別、2020～2034年
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東・アフリカ
ラテンアメリカ
- ラテンアメリカ：適応症別、2020年～2034年
- ラテンアメリカ：剤形別、2020～2034年
- ラテンアメリカ：投与経路別、2020～2034年
- ラテンアメリカ：流通チャネル別、2020年～2034年
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第10章競合情勢

事業拡大・買収分析
- 事業拡大
- 買収
提携/協業/協定/公開

第11章企業プロファイル

AbbVie Inc.
AdvaCare Pharma
Apotex Inc.
Cipla Ltd.
Harrow, Inc.
Lupin Pharmaceuticals, Inc.
Novartis AG
Santen Pharmaceutical Co., Ltd.
Strides Pharma Science Ltd.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries
Viatris Inc.

図表

List of Tables:

Table 1 Global Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 2 Global Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 3 Global Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 4 Global Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 5 North America: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 6 North America: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 7 North America: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 8 North America: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 9 U.S.: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 10 U.S.: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 11 U.S.: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 12 U.S.: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 13 Canada: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 14 Canada: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 15 Canada: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 16 Canada: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 17 Europe: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 18 Europe: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 19 Europe: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 20 Europe: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 21 UK: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 22 UK: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 23 UK: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 24 UK: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 25 France: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 26 France: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 27 France: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 28 France: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 29 Germany: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 30 Germany: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 31 Germany: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 32 Germany: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 33 Italy: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 34 Italy: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 35 Italy: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 36 Italy: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 37 Spain: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 38 Spain: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 39 Spain: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 40 Spain: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 41 Netherlands: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 42 Netherlands: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 43 Netherlands: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 44 Netherlands: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 45 Russia: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 46 Russia: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 47 Russia: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 48 Russia: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 49 Rest of Europe: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 50 Rest of Europe: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 51 Rest of Europe: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 52 Rest of Europe: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 53 Asia Pacific: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 54 Asia Pacific: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 55 Asia Pacific: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 56 Asia Pacific: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 57 China: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 58 China: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 59 China: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 60 China: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 61 India: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 62 India: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 63 India: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 64 India: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 65 Malaysia: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 66 Malaysia: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 67 Malaysia: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 68 Malaysia: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 69 Japan: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 70 Japan: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 71 Japan: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 72 Japan: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 73 Indonesia: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 74 Indonesia: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 75 Indonesia: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 76 Indonesia: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 77 South Korea: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 78 South Korea: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 79 South Korea: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 80 South Korea: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 81 Australia: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 82 Australia: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 83 Australia: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 84 Australia: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 85 Rest of Asia Pacific: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 86 Rest of Asia Pacific: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 87 Rest of Asia Pacific: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 88 Rest of Asia Pacific: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 89 Middle East & Africa: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 90 Middle East & Africa: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 91 Middle East & Africa: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 92 Middle East & Africa: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 93 Saudi Arabia: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 94 Saudi Arabia: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 95 Saudi Arabia: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 96 Saudi Arabia: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 97 UAE: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 98 UAE: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 99 UAE: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 100 UAE: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 101 Israel: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 102 Israel: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 103 Israel: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 104 Israel: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 105 South Africa: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 106 South Africa: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 107 South Africa: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 108 South Africa: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 109 Rest of Middle East & Africa: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 110 Rest of Middle East & Africa: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 111 Rest of Middle East & Africa: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 112 Rest of Middle East & Africa: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 113 Latin America: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 114 Latin America: Cyclosporine Market, by Dosage Form , 2020-2034 (USD Billion)
Table 115 Latin America: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 116 Latin America: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 117 Mexico: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 118 Mexico: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 119 Mexico: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 120 Mexico: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 121 Brazil: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 122 Brazil: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 123 Brazil: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 124 Brazil: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 125 Argentina: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 126 Argentina: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 127 Argentina: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 128 Argentina: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 129 Rest of Latin America: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
Table 130 Rest of Latin America: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
Table 131 Rest of Latin America: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
Table 132 Rest of Latin America: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Cyclosporine Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Indication Type
Figure 7. Global Cyclosporine Market, by Indication Type, 2024 & 2034 (USD Billion)
Figure 8. Market by Dosage Form
Figure 9. Global Cyclosporine Market, by Dosage Form, 2024 & 2034 (USD Billion)
Figure 10. Market by Route of Administration
Figure 11. Global Cyclosporine Market, by Route of Administration, 2024 & 2034 (USD Billion)
Figure 12. Market by Distribution Channel
Figure 13. Global Cyclosporine Market, by Distribution Channel, 2024 & 2034 (USD Billion)

Product Code: PM6000

The cyclosporine market size is expected to reach USD 7.06 Billion by 2034, according to a new study by Polaris Market Research. The report "Cyclosporine Market Share, Size, Trends, Industry Analysis Report: By Indication (Transplant rejection prophylaxis, Rheumatoid arthritis, Psoriasis), By Dosage Form, By Route of Administration, By Distribution Channel, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Cyclosporine is an immunosuppressive agent widely used to prevent organ transplant rejection and manage autoimmune conditions, where precise immune modulation is crucial for treatment success. Developed under stringent clinical protocols, it ensures controlled immune response and consistent therapeutic outcomes. The market continues to grow as healthcare systems expand access to advanced immunosuppressive therapies for systemic and ophthalmic applications.

The market growth is fueled by rising government healthcare spending and the increasing number of organ transplantation procedures globally. The rising advancement in drug formulations and delivery systems are enhancing patient compliance and therapeutic efficiency. Additionally, the expanding prevalence of autoimmune disorders and chronic ocular inflammation is driving the broader clinical adoption of cyclosporine across multiple specialties.

Cyclosporine Market Report Highlights

Based on indication, the transplant rejection prophylaxis segment dominated the market in 2024, due to the rising number of kidney, liver, and heart transplant surgeries requiring long-term immunosuppressive therapy.

Based on dosage form, the eye drops segment is expected to witness the fastest growth, driven by increasing diagnoses of dry eye disease and chronic ocular surface inflammation.

Based on route of administration, the oral segment held the dominant market share in 2024, driven by its use in systemic autoimmune conditions and widespread availability across hospital and retail channels.

Based on distribution channel, the hospital pharmacies segment held the dominant share in 2024, due to the centralized management of post-transplant medication regimens and the high demand for physician-supervised dispensing of immunosuppressants.

North America accounted for largest share of the global cyclosporine market in 2024, fueled by strong healthcare spending and robust adoption of generic immunosuppressive therapies.

Asia Pacific is expected to grow fastest during the forecast period, due to increasing access to organ transplantation and growing prevalence of autoimmune diseases.

A few global key market players include AbbVie Inc., AdvaCare Pharma, Apotex Inc., Cipla Ltd., Harrow, Inc., Lupin Pharmaceuticals, Inc., Novartis AG, Santen Pharmaceutical Co., Ltd., Strides Pharma Science Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries, and Viatris Inc.

Polaris Market Research has segmented the market report on the basis of indication, dosage form, route of administration, distribution channel, and region:

By Indication Outlook (Revenue, USD Billion, 2020-2034)

Transplant rejection prophylaxis

Rheumatoid arthritis

Psoriasis

Autoimmune myasthenia gravis

Dry eye

Other indications

By Dosage Form Outlook (Revenue, USD Billion, 2020-2034)

Capsule

Eye drops

Liquid solutions

Creams and ointments

By Route of Administration (Revenue, USD Billion, 2020-2034)

Oral

Intravenous

Topical

By Distribution Channel (Revenue, USD Billion, 2020-2034)

Hospital pharmacies

Retail pharmacies

Online pharmacies

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin Americ

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Cyclosporine Market Insights

4.1. Cyclosporine Market - Market Snapshot
4.2. Cyclosporine Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Government Healthcare Spending
  - 4.2.1.2. Rising Cases of Organ Transplant Procedures Worldwide
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Availability of Alternatives
  - 4.2.2.2. Competition from Alternative Recreational Options
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Cyclosporine Market Trends
4.6. Value Chain Analysis

5. Global Cyclosporine Market, by Indication Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
5.3. Transplant rejection prophylaxis
- 5.3.1. Global Cyclosporine Market, by Transplant rejection prophylaxis, by Region, 2020-2034 (USD Billion)
5.4. Rheumatoid arthritis
- 5.4.1. Global Cyclosporine Market, by Rheumatoid arthritis, by Region, 2020-2034 (USD Billion)
5.5. Psoriasis
- 5.5.1. Global Cyclosporine Market, by Psoriasis, by Region, 2020-2034 (USD Billion)
5.6. Autoimmune myasthenia gravis
- 5.6.1. Global Cyclosporine Market, by Autoimmune myasthenia gravis, by Region, 2020-2034 (USD Billion)
5.7. Dry eye
- 5.7.1. Global Cyclosporine Market, by Dry eye, by Region, 2020-2034 (USD Billion)
5.8. Other indications
- 5.8.1. Global Cyclosporine Market, by Other indications, by Region, 2020-2034 (USD Billion)

6. Global Cyclosporine Market, by Dosage Form

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
6.3. Capsule
- 6.3.1. Global Cyclosporine Market, by Capsule, by Region, 2020-2034 (USD Billion)
6.4. Eye drops
- 6.4.1. Global Cyclosporine Market, by Eye drops, by Region, 2020-2034 (USD Billion)
6.5. Liquid solutions
- 6.5.1. Global Cyclosporine Market, by Liquid solutions, by Region, 2020-2034 (USD Billion)
6.6. Creams and ointments
- 6.6.1. Global Cyclosporine Market, by Creams and ointments, by Region, 2020-2034 (USD Billion)

7. Global Cyclosporine Market, by Route of Administration

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
7.3. Oral
- 7.3.1. Global Cyclosporine Market, by Oral, by Region, 2020-2034 (USD Billion)
7.4. Intravenous
- 7.4.1. Global Cyclosporine Market, by Intravenous, by Region, 2020-2034 (USD Billion)
7.5. Topical
- 7.5.1. Global Cyclosporine Market, by Topical, by Region, 2020-2034 (USD Billion)

8. Global Cyclosporine Market, by Distribution Channel

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
8.3. Hospital pharmacies
- 8.3.1. Global Cyclosporine Market, by Hospital pharmacies, by Region, 2020-2034 (USD Billion)
8.4. Retail pharmacies
- 8.4.1. Global Cyclosporine Market, by Retail pharmacies, by Region, 2020-2034 (USD Billion)
8.5. Online pharmacies
- 8.5.1. Global Cyclosporine Market, by Online pharmacies, by Region, 2020-2034 (USD Billion)

9. Global Cyclosporine Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Cyclosporine Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Cyclosporine Market - North America
- 9.3.1. North America: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
- 9.3.2. North America: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
- 9.3.3. North America: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.3.4. North America: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.3.5. Cyclosporine Market - U.S.
  - 9.3.5.1. U.S.: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.3.5.2. U.S.: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.3.5.3. U.S.: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.3.5.4. U.S.: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.3.6. Cyclosporine Market - Canada
  - 9.3.6.1. Canada: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
9.4. Cyclosporine Market - Europe
- 9.4.1. Europe: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
- 9.4.3. Europe: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.4. Europe: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.5. Cyclosporine Market - UK
  - 9.4.5.1. UK: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.6. Cyclosporine Market - France
  - 9.4.6.1. France: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.4.6.2. France: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.4.6.3. France: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.6.4. France: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.7. Cyclosporine Market - Germany
  - 9.4.7.1. Germany: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: Cyclosporine Market, by Dosage Form ,2020-2034 (USD Billion)
  - 9.4.7.3. Germany: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.8. Cyclosporine Market - Italy
  - 9.4.8.1. Italy: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.9. Cyclosporine Market - Spain
  - 9.4.9.1. Spain: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.10. Cyclosporine Market - Netherlands
  - 9.4.10.1. Netherlands: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.11. Cyclosporine Market - Russia
  - 9.4.11.1. Russia: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.12. Cyclosporine Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
9.5. Cyclosporine Market - Asia Pacific
- 9.5.1. Asia Pacific: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.5. Cyclosporine Market - China
  - 9.5.5.1. China: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.5.5.2. China: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.5.5.3. China: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.5.4. China: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.6. Cyclosporine Market - India
  - 9.5.6.1. India: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.5.6.2. India: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.5.6.3. India: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.6.4. India: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.7. Cyclosporine Market - Malaysia
  - 9.5.7.1. Malaysia: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.8. Cyclosporine Market - Japan
  - 9.5.8.1. Japan: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.9. Cyclosporine Market - Indonesia
  - 9.5.9.1. Indonesia: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.10. Cyclosporine Market - South Korea
  - 9.5.10.1. South Korea: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.11. Cyclosporine Market - Australia
  - 9.5.11.1. Australia: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.12. Cyclosporine Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
9.6. Cyclosporine Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.6.5. Cyclosporine Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.6.6. Cyclosporine Market - UAE
  - 9.6.6.1. UAE: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.6.7. Cyclosporine Market - Israel
  - 9.6.7.1. Israel: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.6.8. Cyclosporine Market - South Africa
  - 9.6.8.1. South Africa: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.6.9. Cyclosporine Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
9.7. Cyclosporine Market - Latin America
- 9.7.1. Latin America: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.7.5. Cyclosporine Market - Mexico
  - 9.7.5.1. Mexico: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.7.6. Cyclosporine Market - Brazil
  - 9.7.6.1. Brazil: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.7.7. Cyclosporine Market - Argentina
  - 9.7.7.1. Argentina: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.7.8. Cyclosporine Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Cyclosporine Market, by Indication Type, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Cyclosporine Market, by Dosage Form, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Cyclosporine Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Cyclosporine Market, by Distribution Channel, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. AbbVie Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. AdvaCare Pharma
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Apotex Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Cipla Ltd.
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Harrow, Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Lupin Pharmaceuticals, Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Novartis AG
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Santen Pharmaceutical Co., Ltd.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Strides Pharma Science Ltd.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Sun Pharmaceutical Industries Ltd.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Teva Pharmaceutical Industries
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Viatris Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development

シクロスポリンの世界市場、規模、シェア、産業分析レポート：適応症別、剤形別、投与経路別、流通チャネル別、地域別 - 市場予測（2025年～2034年）

Cyclosporine Market Size, Share, & Industry Analysis Report By Indication (Transplant rejection prophylaxis, Rheumatoid arthritis), By Dosage Form, By Route of Administration, By Distribution Channel, and By Region - Market Forecast, 2025-2034

シクロスポリン市場レポートのハイライト

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界のシクロスポリン市場の洞察

第5章世界のシクロスポリン市場：適応症別

第6章世界のシクロスポリン市場：剤形別

第7章世界のシクロスポリン市場：投与経路別

第8章世界のシクロスポリン市場：流通チャネル別

第9章世界のシクロスポリン市場：地域別

第10章競合情勢

第11章企業プロファイル

List of Tables:

List of Figures:

Cyclosporine Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Cyclosporine Market Insights

5. Global Cyclosporine Market, by Indication Type

6. Global Cyclosporine Market, by Dosage Form

7. Global Cyclosporine Market, by Route of Administration

8. Global Cyclosporine Market, by Distribution Channel

9. Global Cyclosporine Market, by Geography

10. Competitive Landscape

11. Company Profiles

シクロスポリンの世界市場、規模、シェア、産業分析レポート：適応症別、剤形別、投与経路別、流通チャネル別、地域別 - 市場予測（2025年～2034年）

Cyclosporine Market Size, Share, & Industry Analysis Report By Indication (Transplant rejection prophylaxis, Rheumatoid arthritis), By Dosage Form, By Route of Administration, By Distribution Channel, and By Region - Market Forecast, 2025-2034

シクロスポリン市場レポートのハイライト

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のシクロスポリン市場の洞察

第5章 世界のシクロスポリン市場：適応症別

第6章 世界のシクロスポリン市場：剤形別

第7章 世界のシクロスポリン市場：投与経路別

第8章 世界のシクロスポリン市場：流通チャネル別

第9章 世界のシクロスポリン市場：地域別

第10章 競合情勢

第11章 企業プロファイル

List of Tables:

List of Figures:

Cyclosporine Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Cyclosporine Market Insights

5. Global Cyclosporine Market, by Indication Type

6. Global Cyclosporine Market, by Dosage Form

7. Global Cyclosporine Market, by Route of Administration

8. Global Cyclosporine Market, by Distribution Channel

9. Global Cyclosporine Market, by Geography

10. Competitive Landscape

11. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界のシクロスポリン市場の洞察

第5章世界のシクロスポリン市場：適応症別

第6章世界のシクロスポリン市場：剤形別

第7章世界のシクロスポリン市場：投与経路別

第8章世界のシクロスポリン市場：流通チャネル別

第9章世界のシクロスポリン市場：地域別

第10章競合情勢

第11章企業プロファイル